Skip to main content

Taurine and Friedreich’s Ataxia: An Update

  • Chapter
Taurine in Nutrition and Neurology

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 139))

Abstract

Friedreich’s ataxia is a recessively inherited spino-cerebellar ataxia appearing in childhood and relentlessly progressing to invalidity or death in middle age at the latest. A number of signs and symptoms have been found to be present in 100% of patients and are obligatory for a diagnosis, while other signs are definitely of a progressive nature (19). Incoordination of limbs (ataxia) is linked to evidence of damage to the posterior columns of the spinal cord and of dorsal root ganglia (loss of vibration and position sense), and of the pyramidal tract (absence of knee and ankle jerks, trophic changes). Most of these symptoms first appear in the lower limbs. Also observed are skeletal deformities (pes cavus, kyphoscoliosis). Electrically, almost all cases of the typical disease have absent or considerably diminished sensory action potentials in the sural nerves, while motor conduction velocities are either normal or only slightly decreased. Retinitis pigmentosa is not usually seen in typical Friedreich’s ataxia, but it is often present in association with a variety of other forms of hereditary ataxia. A final feature of Friedreich’s ataxia that must be stressed is the constant presence of a cardiomyopathy as evidenced by abnormal echocardiograms, vectocardiograms or electrocardiograms, singly or in combination. This cardiomyopathy is usually hypertrophic in type and occasionally obstructive; it appears to be an integral part of Friedreich’s ataxia, and not a phenomenon secondary to the disease process. The most important histological changes are myocardial fibrosis and foci of degeneration of the cardiac muscle cells. Granular deposits of calcium or iron salts can occasionally be found in these muscle cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Azari, J., Brumbaugh, P., Barbeau, A., and Huxtable, R., 1980, Taurine decreases lesion severity in the heart of cardiomyopathic hamsters, Can. J. Neurol. Sci., 7: 435–440.

    CAS  Google Scholar 

  2. Barbeau, A., Inoue, N., Tsukada, Y., and Butterworth, R.F., 1975, Minireview: the neuropharmacology of taurine, Life Science, 17: 669–678.

    Article  CAS  Google Scholar 

  3. Barbeau, A., Tsukada, Y., and Inoue, N., Neuropharmacologic and behavioral effects of taurine, in: “Taurine,” R. Huxtable and A. Barbeau, eds., Raven Press, New York (1976), pp. 253–266.

    Google Scholar 

  4. Barbeau, A., 1976, Friedreich’s ataxia 1976 - An Overview, Can. J. Neurol. Sci., 3: 389–397.

    CAS  Google Scholar 

  5. Barbeau, A., 1978, Friedreich’s ataxia 1978 — An Overview, Can J. Neurol. Sci., 5: 161–165.

    CAS  Google Scholar 

  6. Barbeau, A., Taurine and Friedreich’s ataxia, in: “Taurine and Neurological Disorders,” A. Barbeau and R.J. Huxtable, eds., Raven Press, New York (1978), pp. 429–440.

    Google Scholar 

  7. Barbeau, A., 1979, Friedreich’s ataxia 1979 - An Overview, Can J. Neurol. Sci., 6: 311–319.

    CAS  Google Scholar 

  8. Barbeau, A., 1980, Friedreich’s ataxia 1980 - An Overview of the physiopathology, Can J. Neurol. Sci., 7: 455–468.

    CAS  Google Scholar 

  9. Bland, W.H., Bloom, A., and Drell, W., 1955, Qualitative study of amino aciduria in muscular dystrophy and myotonia dystrophica, Proc. Soc. Exp. Biol. Med., 90: 704–706.

    Google Scholar 

  10. Brotherton, J., 1969, Studies on the metabolism of the rat retina with special reference to retinitis pigmentosa. 2-amino acid content as shown by chromatography, Exp. Eye Res., 3: 837–843.

    Google Scholar 

  11. Butterworth, R.F., Hamel, E., Landreville, F., and Barbeau, A., 1979, Amino acid changes in thiamine-deficient encephalopathy: some implications for the pathogenesis of Friedreich’s ataxia, Can. J. Neurol. Sci., 6: 217–222.

    CAS  Google Scholar 

  12. Butterworth, R.F., Hamel, E., Landreville, F., and Barbeau, A., 1978, Cerebellar ataxia produced by 3-acetyl pyridine in rat. Can. J. Neurol. Sci., 5: 131–133.

    PubMed  CAS  Google Scholar 

  13. Chesney, R.W., Jax, D.K., Scriver, C.R., and Mohyuddin, F., Taurine transport in mammalian kidney, in: “Taurine and Neurological Disorders,” A. Barbeau and R.J. Huxtable, eds., Raven Press, New York (1978), pp. 73–93.

    Google Scholar 

  14. Darsee, J.R., and Heymsfield, S.B. 1981, Decreased myocardial taurine levels and hypertaurinuria in a kindred with mitral-valve prolapse and congestive cardiomyopathy, New Eng. J. Med., 304: 129–135.

    CAS  Google Scholar 

  15. De Michele, G., Jolicoeur, F.B., Rondeau, D.B., Butterworth, R.F., and Barbeau, A., 1980, Effects of glutamate and aspartate on ataxic gait induced by 3-acetyl pryidine in rats, Can J. Neurol. Sci., 7: 451–454.

    Google Scholar 

  16. Dolora, P., Agresti, A., Giotti, A., and Pasquini, G., 1973, Effect of taurine on calcium kinetics of Guinea pig heart, Eur. J. Pharmacol., 24: 352–358.

    Article  Google Scholar 

  17. Filla, A., Butterworth, R.F., Geoffroy, G., Lemieux, B., and Barbeau, A., 1978, Platelet taurine uptake in spinocerebellar degeneration, Can. J. Neurol. Sci., 5: 119–123.

    PubMed  CAS  Google Scholar 

  18. Filla, A., Butterworth, R.F., and Barbeau, A., 1979, Pilot studies on membranes and some transport mechanisms in Friedreich’s ataxia, Can. J. Neurol. Sci., 6: 285–289.

    PubMed  CAS  Google Scholar 

  19. Geoffroy, G., Barbeau, A., Breton, G., Lemieux, B., Aube, M., Leger, C., and Bouchard, M.P., 1976, Clinical description and roentgenologic evaluation of patients with Friedreich’s ataxia, Can. J. Neurol. Sci., 3: 279–286.

    Google Scholar 

  20. Goodman, H.O., Connally, B.M., McLean, W., and Resnick, M., 1980, Taurine transport in epilepsy, Clin. Chem., 26: 414–419.

    PubMed  CAS  Google Scholar 

  21. Hall, C.D., Stowe, F.R., and Summer, G.K., 1974, Familial cerebellar dyssynergia and myoclonus epilepsy associated with a defect of amino acid metabolism, Neurology, 24: 375.

    Google Scholar 

  22. Hayes, K.C., Carey, R.E., and Schmidt, S.Y., 1975, Retinal degeneration associated with taurine deficiency in the cat, Science, 188: 949–951.

    Article  PubMed  CAS  Google Scholar 

  23. Hayes, K.C., Rabin, A.R., and Berson, E.L., 1975, An ultrastructural study of nutritionally - induced and reversed retinal degeneration in cats, Am. J. Pathol. 78: 505–524.

    PubMed  CAS  Google Scholar 

  24. Huxtable, R.J., and Bressler, R., 1974, Taurine concentration in congestive heart failure, Science, 198: 409–411.

    Article  Google Scholar 

  25. Huxtable, R.J., 1978, Cardiac pharmacology and cardiomyopathy in Friedreich’s ataxia, Can. J. Neurol. Sci., 5: 83–92.

    CAS  Google Scholar 

  26. Huxtable, R.J., Azari, J., Reisine, T., Johnson, P., Yamamura, H., and Barbeau, A., 1979, Regional distribution of amino acids in Friedreich’s ataxia brains, Can. J. Neurol. Sci., 6: 255–258.

    CAS  Google Scholar 

  27. Izumi, K., Butterworth, R.F., and Barbeau, A., 1977, Effect of taurine on calcium binding to microsomes isolated from rat cerebral cortex, Life Sciences, 20: 943–950.

    Article  PubMed  CAS  Google Scholar 

  28. Izumi, K., Ngo, T.T., and Barbeau, A., Metabolic modulation in the central nervous system by taurine, in: “Taurine and Neurological Disorders,” A. Barbeau and R.J. Huxtable, eds., Raven Press, New York, (1978), pp. 137–149.

    Google Scholar 

  29. Jacobsen, J.G., and Smith, L.L.H., 1968, Biochemistry and physiology of taurine and taurine derivatives, Physiol. Rev., 48: 424–511.

    PubMed  CAS  Google Scholar 

  30. Lemieux, B., Barbeau, A., Beroniade, V., Shapcott, D., Breton, G., Geoffroy, G., and Melancon, S., 1976, Amino Acid metabolism in Friedreich’s ataxia, Can. J. Neurol. Sci., 3: 373–378.

    PubMed  CAS  Google Scholar 

  31. Lemieux, B., Giguere, R., Barbeau, A., Melancon, S., and Shapcott, D., 1978, Taurine in cerebrospinal fluid in Friedreich’s ataxia, Can. J. Neurol. Sci., 5: 125–129.

    CAS  Google Scholar 

  32. McBride, W.J. and Frederickson, R.C.A., Neurochemical and neurophysiological evidence for a role of taurine as an inhibitory neurotransmitter in the cerebellum of the rat, in: “Taurine and Neuological Disorders,” A. Barbeau and R.J. Huxtable, eds., Raven Press, New York (1978), pp. 415–427.

    Google Scholar 

  33. Melancon, S.B., Grignon, B., Ledru, E., Geoffroy, G., Potier, M., Dallaire, L., and Vanasse, M., 1980, The Beta-amino acid transport system in Friedreich’s ataxia, Can. J. Neurol. Sci., 7: 441–446.

    CAS  Google Scholar 

  34. Nevin, N.C., Hurwitz, L.J., and Neill, D.W., 1964, Camptodactyly with mental deficiency, J. Med. Genet.. 3: 265–268.

    Article  Google Scholar 

  35. Reccia, R., Pignalosa, B., Grasso, A., and Campanella, G., 1980, Taurine treatment in retinitis pigmentosa, Acta Neurologica (Napoli), 18: 132–136.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Plenum Press, New York

About this chapter

Cite this chapter

Barbeau, A., Melancon, S., Huxtable, R.J., Lemieux, B. (1982). Taurine and Friedreich’s Ataxia: An Update. In: Huxtable, R.J., Pasantes-Morales, H. (eds) Taurine in Nutrition and Neurology. Advances in Experimental Medicine and Biology, vol 139. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0402-0_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-0402-0_25

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-0404-4

  • Online ISBN: 978-1-4757-0402-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics